Evidence map›Paper›PMID 34548396›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Assembly and organization of the N-terminal region of mucin MUC5AC: Indications for structural and functional distinction from MUC5B.

Jerome Carpenter, Yang Wang, Richa Gupta, Yuanli Li, Prashamsha Haridass, Durai B Subramani, Boris Reidel, Lisa Morton, Caroline Ridley, Wanda K O'Neal and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mucins and Respiratory Virus Infection.Annual review of virology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Modeling chronic infection withInfection and immunity · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. A Coarse-Grained MARTINI Model for Mucins.Journal of chemical theory and computation · 2026
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Highly Branched Sulfated Glycopolymers as Mucin Mimetics.Journal of the American Chemical Society · 2025
    Article
  19. Article
  20. [Protective effect ofNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Jerome CarpenterMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.ORCID 0000-0001-7612-3363
Yang WangMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Richa GuptaMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.ORCID 0000-0002-4885-8036
Yuanli LiMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Prashamsha HaridassMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Durai B SubramaniMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Boris ReidelMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Lisa MortonMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Caroline RidleyWellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom.
Wanda K O'NealMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
Marie-Pierre BuisineUMR9020-U1277 CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), Université Lille, CNRS, Inserm, CHU Lille, F5900 Lille, France.ORCID 0000-0002-3255-5380
Camille EhreMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248.
David J ThorntonWellcome Trust Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom.ORCID 0000-0001-7148-1970
Mehmet KesimerMarsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27517-7248; kesimer@med.unc.edu.
University of North Carolina at Chapel Hill · USWellcome Centre for Cell-Matrix Research · GBCentre National de la Recherche Scientifique · FR

Funding

SPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9M
The role of mucin-protein interactions in the innate defense of the lungR01HL103940 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KESIMER, MEHMET · 2010 to 2014
$1.8M
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary studyR01HL110906 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KESIMER, MEHMET · 2011 to 2014
$1.4M
Medical Research Council MR/R002800/1NHLBI NIH HHS R01 HL103940NHLBI NIH HHS R01 HL110906NHLBI NIH HHS U01 HL137880Wellcome TrustWellcome Trust 088785/Z/09/Z
6 · The paper itself

Abstract

Elevated levels of MUC5AC, one of the major gel-forming mucins in the lungs, are closely associated with chronic obstructive lung diseases such as chronic bronchitis and asthma. It is not known, however, how the structure and/or gel-making properties of MUC5AC contribute to innate lung defense in health and drive the formation of stagnant mucus in disease. To understand this, here we studied the biophysical properties and macromolecular assembly of MUC5AC compared to MUC5B. To study each native mucin, we used Calu3 monomucin cultures that produced MUC5AC or MUC5B. To understand the macromolecular assembly of MUC5AC through N-terminal oligomerization, we expressed a recombinant whole N-terminal domain (5ACNT). Scanning electron microscopy and atomic force microscopy imaging indicated that the two mucins formed distinct networks on epithelial and experimental surfaces; MUC5B formed linear, infrequently branched multimers, whereas MUC5AC formed tightly organized networks with a high degree of branching. Quartz crystal microbalance-dissipation monitoring experiments indicated that MUC5AC bound significantly more to hydrophobic surfaces and was stiffer and more viscoelastic as compared to MUC5B. Light scattering analysis determined that 5ACNT primarily forms disulfide-linked covalent dimers and higher-order oligomers (i.e., trimers and tetramers). Selective proteolytic digestion of the central glycosylated region of the full-length molecule confirmed that MUC5AC forms dimers and higher-order oligomers through its N terminus. Collectively, the distinct N-terminal organization of MUC5AC may explain the more adhesive and unique viscoelastic properties of branched, highly networked MUC5AC gels. These properties may generate insight into why/how MUC5AC forms a static, "tethered" mucus layer in chronic muco-obstructive lung diseases.

Indexed as

Cells, CulturedEpithelial CellsHumansMucin 5ACMucin-5BRespiratory MucosaMUC5AC protein, humanMUC5B protein, humanMucin 5ACMucin-5BairwayslungMUC5ACmucinmucus gel

Identifiers

PMID34548396
PMCPMC8488587
OpenAlexW3199753407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.